Hartford Funds Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Hartford Funds Management's LLY Position: Q1 2026 in Review
Hartford Funds Management reduced its Eli Lilly (LLY) stake by 2.8% in Q1 2026, selling an estimated $92.3K and leaving 3,123 shares worth $2.87M. The position accounts for 0.25% of the portfolio, ranked #18.
Hartford Funds Management first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.46M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Hartford Funds Management held 3,123 shares of Eli Lilly worth $2.87M as of Q1 2026.
- Hartford Funds Management sold 91 Eli Lilly shares in Q1 2026, an estimated $92.3K.
- Eli Lilly made up 0.25% of Hartford Funds Management's portfolio in Q1 2026, its #18 holding.
- Hartford Funds Management first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
- Hartford Funds Management's Eli Lilly position peaked at $3.46M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Hartford Funds Management's 13F filing for Q1 2026, filed 4 May 2026.